| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |